Aimei Health Technology Resultados de beneficios anteriores
Pasado controles de criterios 0/6
There is insufficient data on Aimei Health Technology's performance over the last few years.
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de la industria Capital Markets | 10.3% |
| Tasa de crecimiento de los ingresos | n/a |
| Rentabilidad financiera | n/a |
| Margen neto | n/a |
| Última actualización de beneficios | 30 Jun 2024 |
Actualizaciones de resultados anteriores recientes
No hay actualizaciones
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Aimei Health Technology. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 23 | 0 | 0 | 0 | 0 |
Ingresos de calidad: AFJK has a large one-off loss of $1.4M impacting its last 12 months of financial results to 30th June, 2024.
Margen de beneficios creciente: Insufficient data to determine if AFJK's profit margins have improved over the past year.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Unable to establish if AFJK's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Acelerando crecimiento: Unable to compare AFJK's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Beneficios vs. Industria: Insufficient data to determine if AFJK's earnings growth over the past year exceeded the Capital Markets industry average.
Rentabilidad financiera
Alta ROE: AFJK's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.